Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat Tuberculosis
出版年份 2021 全文链接
标题
Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat Tuberculosis
作者
关键词
-
出版物
ChemMedChem
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-07-21
DOI
10.1002/cmdc.202100359
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tuberculosis in 2020 — New Approaches to a Continuing Global Health Crisis
- (2020) Ahmad Zaheen et al. NEW ENGLAND JOURNAL OF MEDICINE
- New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
- (2020) Gauri S. Shetye et al. Translational Research
- MmpL3 inhibitors as antituberculosis drugs
- (2020) Min Shao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis for the Inhibition of Mycobacterial MmpL3 by NITD-349 and SPIRO
- (2020) Xiaolin Yang et al. JOURNAL OF MOLECULAR BIOLOGY
- MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
- (2020) Jigar P. Sethiya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis
- (2020) Shahinda S.R. Alsayed et al. BIOORGANIC CHEMISTRY
- Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
- (2019) Wei Li et al. ACS Infectious Diseases
- 1H-benzo[d]imidazole derivatives affect MmpL3 in Mycobacterium tuberculosis
- (2019) Małgorzata Korycka-Machała et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis
- (2019) Rainer Kalscheuer et al. BIOCHEMICAL JOURNAL
- Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
- (2019) Payam Nahid et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Identification of novel scaffolds targeting Mycobacterium tuberculosis
- (2019) Michael Dal Molin et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Treatment of Drug-Resistant Tuberculosis
- (2019) Sundari R. Mase et al. CLINICS IN CHEST MEDICINE
- WHO global progress report on tuberculosis elimination
- (2019) Emilia Harding Lancet Respiratory Medicine
- Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus
- (2019) Clément Raynaud et al. ACS Infectious Diseases
- Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities
- (2018) Kiran Patil et al. BIOMEDICINE & PHARMACOTHERAPY
- In vivo potent BM635 analogue with improved drug-like properties
- (2018) Giovanna Poce et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Genotyping of Mycobacterium tuberculosis using whole genome sequencing
- (2018) Jana Amlerova et al. FOLIA MICROBIOLOGICA
- Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption
- (2018) Annanya Shetty et al. Frontiers in Microbiology
- Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections
- (2017) Alan P. Kozikowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- MmpL3 is the flippase for mycolic acids in mycobacteria
- (2017) Zhujun Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents
- (2016) Remya Ramesh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drug-Resistant Tuberculosis
- (2016) Sebastian G. Kurz et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues
- (2015) Katarzyna Gobis et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
- (2015) Kwonjune J. Seung et al. Cold Spring Harbor Perspectives in Medicine
- Genomic insights into tuberculosis
- (2014) James E. Galagan NATURE REVIEWS GENETICS
- Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties
- (2013) E. Jeffrey North et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Progress in targeting cell envelope biogenesis inMycobacterium tuberculosis
- (2013) Mary Jackson et al. Future Microbiology
- Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
- (2013) Oluseye K. Onajole et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
- (2013) Modesto J. Remuiñán et al. PLoS One
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability
- (2012) Michael S. Scherman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Targeting the mycobacterial envelope for tuberculosis drug development
- (2012) Lorenza Favrot et al. Expert Review of Anti-Infective Therapy
- MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
- (2011) Valentina La Rosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The structure–activity relationship of urea derivatives as anti-tuberculosis agents
- (2011) Joshua R. Brown et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and Biological Aspects of Mycolic Acids: An Important Target AgainstMycobacterium tuberculosis
- (2011) Marcus Vinícius Nora de Souza et al. TheScientificWorldJOURNAL
- Genetic Diversity of Isoniazid-Resistant Mycobacterium tuberculosis Isolates Collected in Poland and Assessed by Spoligotyping
- (2008) E. Augustynowicz-Kopec et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
- (2008) Irith Wiegand et al. Nature Protocols
- Multispacer Sequence Typing for Mycobacterium tuberculosis Genotyping
- (2008) Zoheira Djelouadji et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started